Showing 9131-9140 of 19239 results for "".
- Projected Impacts of Integrated T2D Management in Spainhttps://reachmd.com/news/impacts-of-integrated-t2d-management-spain/2485774/An MDPI Journal of Clinical Medicine modeling analysis estimated the one-year national impact in Spain of simultaneously meeting three biomarke
- Micronutrient Risks During Second‑Generation Incretin Therapyhttps://reachmd.com/news/micronutrient-risks-during-secondgeneration-incretin-therapy/2485744/The narrative review Micronutrient Risks During Second‑Generation Incretin Therapy describes obesity as a setting where micronutrient shortfalls can coexist with excess energy intake, and it plac
- Call Burden and Compensation Disparities in Diagnostic and Interventional Radiologyhttps://reachmd.com/news/call-burden-compensation-disparities-diagnostic-interventional-radiology/2485733/A recent JVIR survey of interventional radiologists describes measurable differences in call burden, remote-work feasibility, and compensation approaches between diagnostic an
- Intermittent Fasting Shows No Greater Weight Loss Than Standard Advicehttps://reachmd.com/news/cochrane-review-intermittent-fasting-shows-no-greater-weight-loss-than-standard-advice/2485712/A recent review compared intermittent fasting with regular dietary advice or no intervention or waiting list among a
- Mepolizumab and IOS-Defined Small Airway Dysfunction in Children: AAAAI Secondary Analysishttps://reachmd.com/news/mepolizumab-and-ios-defined-small-airway-dysfunction-in-children-aaaai-secondary-analysis/2485707/Baseline impulse oscillometry (IOS) measures of airway resistance/reactance (eg, R5, R5-20, and AX)
- Intralesional Cemiplimab: Reported High Pathologic Responses in Early-Stage CSCChttps://reachmd.com/news/intralesional-cemiplimab-reported-high-pathologic-responses-in-early-stage-cscc/2485720/Low-dose intralesional cemiplimab in a Phase 1 pilot expansion cohort
- OHSU-led federally funded initiative to evaluate state-regulated psilocybin serviceshttps://reachmd.com/news/ohsu-led-federally-funded-initiative-to-evaluate-state-regulated-psilocybin-services/2485687/A NIDA-funded implementation research initiative led by Oregon Health & Science University (OHSU)
- Analysis Forecasts 140% Rise in Basal Cell Carcinoma Incidence by 2050https://reachmd.com/news/analysis-forecasts-140-rise-in-basal-cell-carcinoma-incidence-by-2050/2485719/An analysis projected that incident basal cell carcinoma (BCC) among adults aged 65 ye
- Commentary: Is the IMQ Mouse Model Hindering Psoriasis Research?https://reachmd.com/news/commentary-is-the-imq-mouse-model-hindering-psoriasis-research/2485698/A perspective piece in the Journal of Investigative Dermatology takes a criticial look at the imiquimod (IMQ) mouse model, suggesting its unversality and commonality may be impeding translational progress in psoriasis resea
- Addiction consults and MOUD initiation in injection-related endogenous endophthalmitishttps://reachmd.com/news/addiction-consults-and-moud-initiation-in-injection-related-endogenous-endophthalmitis/2485690/Hospitalized patients with injection-drug-use–associated endogenous endophthalmitis were described in a Mass General Brigham report